SPONSOR
Instituto do Cancer do Estado de São Paulo
Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Urachal CancerParathyroid CarcinomaFibrolamellar CarcinomaAngiosarcomaSecretory Carcinoma of BreastAnal NeoplasmsMetaplastic Breast CarcinomaTranslocation Renal Cell CarcinomaCarcinosarcomaSmall Intestine Neoplasms
Instituto do Cancer do Estado de São Paulo is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Urachal Cancer, Parathyroid Carcinoma, Fibrolamellar Carcinoma, Angiosarcoma.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Instituto do Cancer do Estado de São Paulo
How many clinical trials has Instituto do Cancer do Estado de São Paulo sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Instituto do Cancer do Estado de São Paulo, of which 1 are actively recruiting participants. These trials cover conditions including Urachal Cancer, Parathyroid Carcinoma, Fibrolamellar Carcinoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Instituto do Cancer do Estado de São Paulo research focus on?
Instituto do Cancer do Estado de São Paulo clinical trials span Urachal Cancer, Parathyroid Carcinoma, Fibrolamellar Carcinoma, Angiosarcoma, Secretory Carcinoma of Breast, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Instituto do Cancer do Estado de São Paulo clinical trial?
To participate in a Instituto do Cancer do Estado de São Paulo trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Instituto do Cancer do Estado de São Paulo trials with current recruitment status updated daily.
Clinical Trials by Instituto do Cancer do Estado de São Paulo
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology